South Korea Analysis

Pages

Industry Trend Analysis - Drugmakers To Continue Overseas Expansion - MAR 2015

Internationalisation will become a critical element in the business strategies of South Korean drugmakers due to pricing controls in the domestic market and the strong commercial opportunities in developing economies. We highlight the importance of emerging markets in South Korea's expansion strategy as the strong role of generic medicines in these countries play to the strengths of many Korean...

READ FULL ARTICLE

Industry Trend Analysis - Biosimilars To Drive Domestic Industry Growth - FEB 2015

Biosimilars will be a key driver of growth for the South Korean pharmaceutical industry. Local manufacturers will boosted by a supportive domestic environment and the upcoming patent expirations for a number of biologic medicines. We highlight that South Korean companies with a focus on biosimilars, including Celltrion, will be well placed to leverage the commercial opportunities.

READ FULL ARTICLE

Pages